About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by FSD Pharma Inc.

< Previous 1 2 Next >
News headline image
FSD Pharma Participating in H.C. Wainwright 24th Annual Global Investment Conference, On-Demand Presentation Available
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Inc. Announces Results of Annual General Meeting of Shareholders And Other Corporate Updates
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Files Investigational New Drug Application (“IND”) with FDA and Health Canada for Phase-2 Trial of FSD-201 for an Inflammatory disorder and Provides Corporate Updates
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Issues Circular, Adopts Incentive Plan and Grants PSUs
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Dismissal of Derivative Complaint
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Issues Corporate Updates
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Filing of Year-End 2021 Results
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Executive Informational Overview Report Produced by Crystal Research Associates LLC
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Agreement for Sale of Cobourg Facility for CAD$16,500,000
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Launch of New Corporate Website
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Share Repurchase Program
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical Models (Mouse Models)
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Expands Research and Clinical Advisory Board with Appointment of World-Renowned Immunologist and Cytokine Expert Dr. Eleanor N. Fish
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for Cause
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
News headline image
FSD Pharma Inc. Appoints a New Independent Director
From FSD Pharma Inc.
Via Business Wire
Tickers CSE:HUGE HUGE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.